Arterra Bioscience SpA (MIL:ARBS) LT-Debt-to-Total-Asset : 0.02 (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Arterra Bioscience SpA LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Arterra Bioscience SpA's long-term debt to total assests ratio for the quarter that ended in Jun. 2024 was 0.02.

Arterra Bioscience SpA's long-term debt to total assets ratio declined from Jun. 2023 (0.03) to Jun. 2024 (0.02). It may suggest that Arterra Bioscience SpA is progressively becoming less dependent on debt to grow their business.

Arterra Bioscience SpA LT-Debt-to-Total-Asset Historical Data

The historical data trend for Arterra Bioscience SpA's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arterra Bioscience SpA LT-Debt-to-Total-Asset Chart

Arterra Bioscience SpA Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.08

0.06

0.03

0.02

Arterra Bioscience SpA Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial									0.03	0.03	0.03	0.02	0.02

Arterra Bioscience SpA LT-Debt-to-Total-Asset Calculation

Arterra Bioscience SpA's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	0.3	/	12.554
	=	0.02

Arterra Bioscience SpA's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (Q: Jun. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jun. 2024 )	/	Total Assets (Q: Jun. 2024 )
	=	0.3	/	12.541
	=	0.02

Arterra Bioscience SpA (MIL:ARBS) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Arterra Bioscience SpA LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Arterra Bioscience SpA's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Arterra Bioscience SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arterra Bioscience SpA (MIL:ARBS) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

via Benedetto Brin, 69, Napoli, ITA, 80142

Website

https://www.arterrabio.it

Arterra Bioscience SpA is a biotechnology company focused on the research and development of ingredients and natural solutions. It engages in the development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds; and production of high-tech raw materials with application in different industrial fields.

Arterra Bioscience SpA Headlines

No Headlines